1. Home
  2. HZO vs ANNX Comparison

HZO vs ANNX Comparison

Compare HZO & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

HOLD

Current Price

$52.45

Market Cap

788.1M

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.15

Market Cap

873.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HZO
ANNX
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
788.1M
873.3M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
HZO
ANNX
Price
$52.45
$4.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$30.00
$16.50
AVG Volume (30 Days)
708.6K
2.6M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$2,309,288,000.00
N/A
Revenue This Year
$3.67
N/A
Revenue Next Year
$4.01
$16,320.74
P/E Ratio
$249.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.42
$2.54
52 Week High
$52.50
$7.18

Technical Indicators

Market Signals
Indicator
HZO
ANNX
Relative Strength Index (RSI) 78.25 36.25
Support Level $52.08 N/A
Resistance Level N/A $5.63
Average True Range (ATR) 0.14 0.21
MACD -0.52 -0.02
Stochastic Oscillator 86.90 29.18

Price Performance

Historical Comparison
HZO
ANNX

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: